Skip to main content
Clinical Trials/CTRI/2023/07/054882
CTRI/2023/07/054882
Not yet recruiting
Phase 4

A comparative study to assess the effects of intrathecalfentanyl and intrathecal tramadol combined with 0.5%bupivacaine heavy in patients undergoing electiveurological surgeries: A prospective randomized study. - NI

Dr Baig Mirza Wajeed0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Baig Mirza Wajeed
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Baig Mirza Wajeed

Eligibility Criteria

Inclusion Criteria

  • Patient giving consent to participate in study and scheduled for elective
  • urosurgery.
  • Age between 20\-60 years
  • ASA grade I and II

Exclusion Criteria

  • Patients not giving consent to participate in the study.
  • ASA grade III and IV
  • Patients with respiratory, cardiovascular, hepatic and renal diseases,
  • obesity and pregnancy.
  • Age below \<20 years and above \>60 years.
  • Any bleeding disorder and patient on anticoagulants.
  • Neurological and musculoskeletal disease.
  • Local infection at the injection site.
  • Patient already receiving any analgesic.
  • Patient already receiving opioid agonist or antagonist in preceding 6 hrs

Outcomes

Primary Outcomes

Not specified

Similar Trials